Tempo Plating System; Ultra Compression Screw System
Pace Surgical · Decision date Sep 3, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision (SESE) on September 3, 2026 for K261647, covering the Tempo Plating System and Ultra Compression Screw System from Pace Surgical. The submission sits under 21 CFR 888.3030 in Class II, orthopedic specialty, with product code HRS listed as primary and HWC also cited. Substantial equivalence is a 510(k) clearance, not premarket approval.
The record describes a plating system and a compression screw system, with plates indicated for bones of the toes, midfoot and hindfoot and non-locking screws indicated for reconstruction, osteotomy, arthrodesis, joint fusion and fracture repair and fixation. The summary lists K250952, K251555 and K203011 as predicate devices. The documents disagree on the received date, showing both August 5, 2026 and May 19, 2026, and the summary is dated September 1, 2026; the record does not resolve this. No clinical performance data are summarized here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261647
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Pace Surgical
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- Pace Surgical
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K261647 received
Application receipt date recorded by FDA.
K261647 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| ARTHREX, INC. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Skeletal Dynamics, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
ANTHEM Fracture SystemK262779 | GLOBUS MEDICAL, INC. | 510(k) clearance | Oct 23, 2026 | FDA |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Pace Surgical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Malvern, PA
Sources and methodology
- Original FDA record: K261647
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


